Regenerative Medical Technology (RMTG) EBITDA (2019 - 2026)
Regenerative Medical Technology's EBITDA came in at $656,787 for Q2 2026, compared with -$195,255 a year earlier and up 100.6% from the prior quarter.
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regenerative Medical Technology reported EBITDA of $406,650, down 10.2% year-over-year; for FY2025, it was -$586,095.
- Going back by year, EBITDA was $301,740 in FY2024, -$405,124 in FY2023, -$1.03 million in FY2022 and -$9.88 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q1 2019.
- Business Quant data shows RMTG's EBITDA at $327,477 (Q1 2026), -$207,931 (Q4 2025) and -$369,683 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Regenerative Medical Technology | 824,338.06 | -3.70 Mn | 2.58 Mn | 656,787.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656,787.00 |
| Mar 31, 2026 | 327,477.00 |
| Dec 31, 2025 | -207,931.00 |
| Sep 30, 2025 | -369,683.00 |
| Jun 30, 2025 | -195,255.00 |
| Mar 31, 2025 | 186,774.00 |
| Dec 31, 2024 | 352,806.00 |
| Sep 30, 2024 | 108,476.00 |
| Jun 30, 2024 | -131,010.00 |
| Mar 31, 2024 | -28,533.00 |
| Dec 31, 2023 | -38,179.00 |
| Sep 30, 2023 | 23,604.00 |
| Jun 30, 2023 | -372,966.00 |
| Mar 31, 2023 | -17,583.00 |
| Dec 31, 2022 | -64,033.00 |
| Sep 30, 2022 | -121,977.00 |
| Jun 30, 2022 | -330,497.00 |
| Mar 31, 2022 | -515,613.00 |
| Dec 31, 2021 | -469,054.00 |
| Sep 30, 2021 | -9.00 Mn |
API Access
Regenerative Medical Technology EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();